ResMed (RMD) director Nicole Mowad-Nassar reports no owned shares

Rhea-AI Filing Summary

ResMed Inc. director reports no beneficial ownership

ResMed Inc. director Nicole Mowad-Nassar filed an initial Form 3 ownership report in connection with an event dated 08/15/2025. The filing states that she serves as a Director of ResMed Inc. and that no securities are beneficially owned, with both the non-derivative and derivative ownership tables showing no holdings.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mowad-Nassar Nicole

(Last) (First) (Middle)

9001 SPECTRUM CENTER BLVD

(Street)

SAN DIEGO CA 92123

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/15/2025

3. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Michael Rider, attorney-in-fact for Ms. Mowad-Nassar	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the ResMed (RMD) Form 3 filed by Nicole Mowad-Nassar show?

The Form 3 for Nicole Mowad-Nassar, a Director of ResMed Inc., reports that she has no securities beneficially owned in the company.

What is the event date for Nicole Mowad-Nassars Form 3 at ResMed (RMD)?

The Form 3 lists an event date of 08/15/2025 as the date requiring the ownership statement.

What is Nicole Mowad-Nassars relationship to ResMed Inc. (RMD)?

The filing identifies Nicole Mowad-Nassar as a Director of ResMed Inc. and not a 10% owner or officer.

Does the ResMed (RMD) Form 3 report any non-derivative securities owned by Nicole Mowad-Nassar?

No. The explanation of responses explicitly states that no securities are beneficially owned, and the non-derivative table reflects no holdings.

Are any derivative securities reported for Nicole Mowad-Nassar in the ResMed (RMD) Form 3?

No derivative securities are listed in the derivative securities table, consistent with the statement that no securities are beneficially owned.

Who signed the Form 3 related to ResMed (RMD) and Nicole Mowad-Nassar?

The Form 3 is signed by /s/ Michael Rider as attorney-in-fact for Ms. Mowad-Nassar, dated 09/02/2025.